Scheithauer Simone, Bludau Anna, Heinemann Stephanie, Anton Martina, Knolle Percy
Institut für Krankenhaushygiene und Infektiologie, Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland.
Lokale Task Force Netzwerk Universitätsmedizin (NUM), Universitätsmedizin Göttingen, Georg-August-Universität Göttingen, Göttingen, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Dec;65(12):1299-1306. doi: 10.1007/s00103-022-03607-x. Epub 2022 Oct 21.
At the beginning of the COVID-19 vaccination campaign in Germany, employees in medical facilities were prioritised for vaccination against SARS-CoV‑2 due to the high risk of exposure and contact with vulnerable groups. Hospitals were therefore encouraged to organise and implement the vaccination of their employees as soon as possible. The aim of the study was to record the practice regarding the vaccination strategy for employees in German hospitals.
In a self-developed cross-sectional study, infection control practitioners of all German university hospitals as well as non-university hospitals in Lower Saxony and Bavaria were surveyed in March 2021. The data were stratified according to the characteristics of university hospitals and non-university hospitals.
Of 416 invitations sent out, 100 questionnaires (university hospitals: 33; non-university hospitals: 67) were completed. University hospitals reported greater vaccination capacity than non-university hospitals, but a limiting factor was uncertain vaccine supply. Vaccination information campaigns were planned or had already been conducted in 89% of clinics. About two-thirds of the respondents (70%) said they did not plan to conduct antibody tests on vaccinated employees. A follow-up of vaccinated employees to detect possible SARS-CoV‑2 infections by PCR was planned by 41% of the respondents. In case of detection of SARS-CoV‑2 infection, 72% of the respondents had planned further diagnostic procedures.
All hospitals were able to achieve rapid implementation of COVID-19 vaccination of their employees. At the time of the survey, there was also much uncertainty regarding the management of breakthrough infections as well as the need for booster vaccinations.
在德国开展新冠疫苗接种运动之初，由于医疗机构员工接触病毒及易感人群的风险较高，因此被列为优先接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的对象。因此，鼓励医院尽快组织并实施员工疫苗接种工作。本研究旨在记录德国医院员工疫苗接种策略的实施情况。
2021年3月，我们开展了一项自行设计的横断面研究，对德国所有大学医院以及下萨克森州和巴伐利亚州的非大学医院的感染控制从业人员进行了调查。数据根据大学医院和非大学医院的特点进行分层。
共发出416份邀请，回收了100份问卷（大学医院：33份；非大学医院：67份）。大学医院报告的疫苗接种能力高于非大学医院，但一个限制因素是疫苗供应不确定。89%的诊所计划或已经开展了疫苗接种宣传活动。约三分之二的受访者（70%）表示他们不打算对接种疫苗的员工进行抗体检测。41%的受访者计划对接种疫苗的员工进行随访，以通过聚合酶链反应（PCR）检测可能的SARS-CoV-2感染。如果检测到SARS-CoV-2感染，72%的受访者计划采取进一步的诊断程序。
所有医院都能够迅速为员工实施新冠疫苗接种。在调查时，对于突破性感染的管理以及加强接种的必要性也存在很多不确定性。
